Hide

FocusBar

FeedbackFeedback
Subscribe to Premium Member
85.61 (1y: +165%)
Market Cap 6.23 B P/E(ttm) 1902.40
Enterprise Value 5.72 B P/B 45.69
PCYC- NAS (USA)
Pharmacyclics, Inc.
  • Currently 1/5
Business Predictability Rank: 1-Star (On Watch)
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies
$85.61
Switch to:
Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,230Revenue $M185Net Margin (%)14.6Z-Score35.0
Enterprise Value $M6,027EPS $1.4Operating Margin %14.5F-Score1
P/E(ttm))1,902Cash Flow Per Share $0.2Pre-tax Margin (%)14.7Higher ROA y-yN
Price/Book45.710-y EBITDA Growth Rate %0Quick Ratio11.2Cash flow > EarningsN
Price/Sales59.05-y EBITDA Growth Rate %0Current Ratio11.5Lower Leverage y-yN
Price/Cash Flow306y-y EBITDA Growth Rate %-156.3ROA % (ttm)5.5Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)9.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M70.5ROI % (ttm)63.5Gross Margin Increase y-yN

Gurus Latest Trades with PCYC

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Number of guru portfolios checked: 51.
TickerGuruDate Action
 Impactdown Price Range
(Average)* 		Current Price Change from Average Comment Current Shares
PCYCJoel Greenblatt 2013-03-31 Sold Out -0.14%$57.78 - $94.2
($77.47)		 $ 85.6110%Sold Out0
PCYCJoel Greenblatt 2012-12-31 Buy 0.14%$47.87 - $69.78
($58.72)		 $ 85.6146%New holding, 41832 sh.41,832
PCYCGeorge Soros 2012-06-30 Sold Out -0.04%$25.72 - $53.44
($32.62)		 $ 85.61162%Sold Out0
PCYCGeorge Soros 2012-03-31 Buy 0.04%$14.99 - $28.68
($20.91)		 $ 85.61309%New holding, 100000 sh.100,000
PCYCPRIMECAP Management 2011-06-30 Add0.01%$5.66 - $10.63
($7.17)		 $ 85.611094%Add 21.34%4,011,958
PCYCPRIMECAP Management 2010-06-30 Add0.01%$5.53 - $8.18
($6.98)		 $ 85.611126%Add 43.36%3,306,481
PCYCPRIMECAP Management 2009-09-30 Add$1.2299 - $2.32
($1.49)		 $ 85.615646%Add 51.48%2,300,678
PCYCPRIMECAP Management 2009-06-30 Reduce$1.02 - $1.39
($1.24)		 $ 85.616804%Reduce -27.71%1,518,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.
Total Records: 8

PCYC is held by these Gurus:

Select Gurus | Default List of Gurus | All Investors | Mutual Fund Gurus | Hedge Fund Gurus
Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PCYC PRIMECAP Management 2013-03-312,440,2393.460.29-15.72%
PCYC Joel Greenblatt 2013-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


PCYC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Buggy Joseph JVP, Research 2013-02-11Sell12,000$69.9722.34view
Loury David JChief Scientific Officer 2013-02-05Sell20,000$70.5821.28view
McGreivy JesseVP, Clinical Science 2013-01-17Sell583$67.2927.21view
Hemmi GregoryVP Chemical Operations 2013-01-11Sell5,000$67.1127.55view
Loury David JChief Scientific Officer 2013-01-09Sell21,062$35.23142.97view
Loury David JChief Scientific Officer 2013-01-08Sell10,000$64.732.3view
Fardis MariaEVP, Operations and Alliances 2013-01-08Sell2,500$6531.69view
Fardis MariaEVP, Operations and Alliances 2013-01-07Sell3,500$64.233.33view
van den Broek RichardDirector 2012-12-31Sell7,171$58.546.32view
van den Broek RichardDirector 2012-12-28Sell30,285$57.9947.61view

Press Releases about PCYC:

Quarterly/Annual Reports about PCYC:

News about PCYC:

Articles On GuruFocus.com
Weekly CEO Buys Highlight: PCYC, HLX, FSC, CREG, BTX Jun 25 2011 
Pharmacyclics Inc. Reports Operating Results (10-Q) Feb 08 2011 
Pharmacyclics Inc. Reports Operating Results (10-Q) Nov 09 2010 
Weekly CEO Buys Highlight: Pharmacyclics Inc, Saul Centers Inc, Charming Shoppes Inc, ProLogis, Exce Jun 27 2010 
Pharmacyclics Inc. Reports Operating Results (10-Q) May 07 2010 
Pharmacyclics Inc. Reports Operating Results (10-Q) Nov 03 2009 

More From Our Partners
FDA Designation for Synageva Candidate - Analyst Blog May 22 2013 - ZACKS

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK